Bessemer Group Inc. Boosts Holdings in Prestige Consumer Healthcare Inc. (NYSE:PBH)

Bessemer Group Inc. grew its stake in shares of Prestige Consumer Healthcare Inc. (NYSE:PBH - Free Report) by 22.7% during the 1st quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 361,958 shares of the company's stock after acquiring an additional 66,908 shares during the period. Bessemer Group Inc. owned 0.73% of Prestige Consumer Healthcare worth $31,118,000 at the end of the most recent reporting period.

A number of other large investors have also recently made changes to their positions in the stock. Sanctuary Advisors LLC lifted its holdings in Prestige Consumer Healthcare by 5.4% during the 4th quarter. Sanctuary Advisors LLC now owns 18,175 shares of the company's stock worth $1,425,000 after purchasing an additional 927 shares in the last quarter. Truist Financial Corp bought a new stake in shares of Prestige Consumer Healthcare during the fourth quarter valued at about $345,000. New York State Common Retirement Fund lifted its holdings in shares of Prestige Consumer Healthcare by 5.1% in the fourth quarter. New York State Common Retirement Fund now owns 16,098 shares of the company's stock worth $1,257,000 after buying an additional 778 shares in the last quarter. Ieq Capital LLC purchased a new stake in shares of Prestige Consumer Healthcare in the fourth quarter worth about $239,000. Finally, Handelsbanken Fonder AB boosted its position in shares of Prestige Consumer Healthcare by 7.6% in the fourth quarter. Handelsbanken Fonder AB now owns 15,581 shares of the company's stock valued at $1,217,000 after acquiring an additional 1,100 shares during the period. 99.95% of the stock is owned by institutional investors.

Analyst Ratings Changes

PBH has been the topic of a number of analyst reports. Wall Street Zen raised shares of Prestige Consumer Healthcare from a "hold" rating to a "buy" rating in a report on Saturday, May 17th. Royal Bank Of Canada raised shares of Prestige Consumer Healthcare to a "hold" rating in a report on Thursday, May 8th. Three research analysts have rated the stock with a hold rating and four have assigned a buy rating to the company. According to MarketBeat, Prestige Consumer Healthcare currently has a consensus rating of "Moderate Buy" and an average price target of $93.33.

Prestige Consumer Healthcare Price Performance

Shares of NYSE:PBH traded down $0.15 during trading on Friday, reaching $81.00. The company had a trading volume of 855,797 shares, compared to its average volume of 303,445. The company has a fifty day moving average of $84.12 and a two-hundred day moving average of $82.48. The company has a current ratio of 4.20, a quick ratio of 2.82 and a debt-to-equity ratio of 0.55. The stock has a market capitalization of $4.00 billion, a P/E ratio of 18.88, a price-to-earnings-growth ratio of 2.44 and a beta of 0.45. Prestige Consumer Healthcare Inc. has a 12 month low of $64.94 and a 12 month high of $90.04.

Prestige Consumer Healthcare (NYSE:PBH - Get Free Report) last released its earnings results on Thursday, May 8th. The company reported $1.32 EPS for the quarter, beating analysts' consensus estimates of $1.30 by $0.02. Prestige Consumer Healthcare had a return on equity of 12.87% and a net margin of 18.86%. The business had revenue of $296.52 million for the quarter, compared to analysts' expectations of $289.36 million. During the same quarter in the prior year, the firm earned $1.02 earnings per share. The firm's revenue was up 7.0% on a year-over-year basis. Equities research analysts forecast that Prestige Consumer Healthcare Inc. will post 4.5 earnings per share for the current year.

Prestige Consumer Healthcare Company Profile

Prestige Consumer Healthcare Inc, together with its subsidiaries, develops, manufactures, markets, distributes, and sells over-the-counter (OTC) health and personal care products in the United States and internationally. The company operates in two segments, North American OTC Healthcare and International OTC Healthcare.